Evidence map›Paper›PMID 27399106›Full record

ArticleMedicine2016

High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs: A multi-centre point prevalence survey.

Ngai Kien Le, Wertheim Hf, Phu Dinh Vu, Dung Thi Khanh Khu, Hai Thanh Le, Bich Thi Ngoc Hoang, Vu Thanh Vo, Yen Minh Lam, Dung Tien Viet Vu, Thu Hoai Nguyen and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prevalence and risk factors ofF1000Research · 2024
    Article
  11. Article
  12. Article
  13. The Changes in Epidemiology of Imipenem-ResistantJournal of Korean medical science · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Review
  18. Article
  19. Emerging carbapenem-resistantMicrobial genomics · 2021
    Article
  20. Novel Detection of Nasty Bugs, Prevention Is Better than Cure.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Ngai Kien LeNational Hospital of Pediatrics, Hanoi Oxford University Clinical Research Unit, Vietnam; Nuffield Department of Medicine, Centre for Tropical Medicine, University of Oxford, UK Department of Medical Microbiology, RCI, Radboudumc, Nijmegen, Netherlands National Hospital for Tropical Diseases, Hanoi Children's Hospital 1, HCMC Hospital for Tropical Diseases, HCMC Linköping University, Sweden Karolinska Institutet, Stockholm, Sweden.
Wertheim Hf
Phu Dinh Vu
Dung Thi Khanh Khu
Hai Thanh Le
Bich Thi Ngoc Hoang
Vu Thanh Vo
Yen Minh Lam
Dung Tien Viet Vu
Thu Hoai Nguyen
Tung Quang Thai
Lennart E Nilsson
Ulf Rydell
Kinh Van Nguyen
Behzad Nadjm
Louise Clarkson
Håkan Hanberger
Mattias Larsson
National Hospital of Pediatrics · VNHospital for Tropical Diseases · VNLinköping University · SEOxford University Clinical Research Unit · VNChildren's Hospital 1 · VNKarolinska Institutet · SE

Funding

Wellcome Trust
6 · The paper itself

Abstract

There is scarce information regarding hospital-acquired infections (HAIs) among children in resource-constrained settings. This study aims to measure prevalence of HAIs in Vietnamese pediatric hospitals.Monthly point prevalence surveys (PPSs) in 6 pediatric intensive care units (ICUs) in 3 referral hospitals during 1 year.A total of 1363 cases (1143 children) were surveyed, 59.9% male, average age 11 months. Admission sources were: other hospital 49.3%, current hospital 36.5%, and community 15.3%. Reasons for admission were: infectious disease (66%), noninfectious (20.8%), and surgery/trauma (11.3%). Intubation rate was 47.8%, central venous catheter 29.4%, peripheral venous catheter 86.2%, urinary catheter 14.6%, and hemodialysis/filtration 1.7%. HAI was diagnosed in 33.1% of the cases: pneumonia (52.2%), septicemia (26.4%), surgical site infection (2%), and necrotizing enterocolitis (2%). Significant risk factors for HAI included age under 7 months, intubation and infection at admission. Microbiological findings were reported in 212 cases (43%) with 276 isolates: 50 Klebsiella pneumoniae, 46 Pseudomonas aeruginosa, and 39 Acinetobacter baumannii, with carbapenem resistance detected in 55%, 71%, and 65%, respectively. Staphylococcus aureus was cultured in 18 cases, with 81% methicillin-resistant Staphylococcus aureus. Most children (87.6%) received antibiotics, with an average of 1.6 antibiotics per case. Colistin was administered to 96 patients, 93% with HAI and 49% with culture confirmed carbapenem resistance.The high prevalence of HAI with carbapenem resistant gram-negative strains and common treatment with broad-spectrum antibiotics and colistin suggests that interventions are needed to prevent HAI and to optimize antibiotic use.

Indexed as

Drug Resistance, BacterialCarbapenemsCross InfectionFemaleGram-Negative Bacterial InfectionsHospitals, PediatricHumansInfantIntensive Care Units, PediatricMalePrevalenceVietnamCarbapenems

Identifiers

PMID27399106
PMCPMC5058835
OpenAlexW2475103991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.